Serum antibodies open the door to prediction and prognostication in human papillomavirus–related head and neck cancer

In human papillomavirus–related head and neck cancer, who can be de-escalated, and who requires more intensive therapy to achieve similar oncologic efficacy? The answers may very well be circulating in saliva and serum. See also pages 000-000.

http://ift.tt/2k0sRaR